Change Language

Select Language

COVID-19
The pandemic continues to cause unprecedented disruption across industries worldwide.
Get detailed insights regarding the impact of COVID-19 on the market.

Artificial Pancreas Device Systems (APDS) Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2021-2026

Market Overview:

The global artificial pancreas device systems (APDS) market reached a value of US$ 1,726 Million in 2020. Looking forward, IMARC Group expects the market to grow at a CAGR of 13.1% during 2021-2026. Keeping in mind the uncertainties of COVID-19, we are continuously tracking and evaluating the direct as well as the indirect influence of the pandemic on different end use sectors. These insights are included in the report as a major market contributor. 

APDS refers to a closed-loop or automated insulin delivery system that manages blood glucose levels by regulating the production of insulin. It consists of a continuous glucose monitor (CGM), a subcutaneous insulin infusion pump and a controller that links the monitor with the pump. It runs a complex algorithm that determines the adequate levels of insulin and time of delivery based on the evaluation of real-time glucose readings. It is primarily used to minimize the risks of extreme fluctuations of glucose levels in the body.

The increasing prevalence of pancreatic cancer, pancreatitis and other chronic ailments is one of the key factors driving the growth of the market. Furthermore, the growing occurrence of diabetes and obesity, due to age-related factors, physical inactivity and unhealthy dietary patterns, is also contributing to the widespread adoption of APDS across the globe. The rising demand for efficient diabetes monitoring and minimally invasive (MI) drug delivery systems is also providing a boost to the market growth. APDS automatically monitors the glucose levels and administers doses of insulin throughout the day in controlled amounts. Various technological innovations, including the development of software-based wireless systems that are integrated with automated controls, are further contributing to the market growth. Moreover, regulatory bodies and governments of various nations are significantly investing in research and development (R&D) for the improvement of healthcare infrastructure across the globe. For instance, the Food and Drug Association (US FDA) in the United States is approving an increasing number of new and innovative products, which is creating a positive outlook for the market in the country. 

Key Market Segmentation:

IMARC Group provides an analysis of the key trends in each sub-segment of the global artificial pancreas device systems (APDS) market, along with forecasts at the global, regional and country level from 2021-2026. Our report has categorized the market based on device type, treatment type and end-user.

Breakup by Device Type:

  • Threshold Suspend Device Systems
  • Control-to-Range Systems
  • Control-to-Target Systems
     

Breakup by Treatment Type:

  • Bi-hormonal
  • Insulin Only
  • Hybrid
     

Breakup by End-User:

  • Hospitals
  • Medical Centres
  • Others
     

Breakup by Region:

  • North America
    • United States
    • Canada
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Australia
    • Indonesia
    • Others
  • Europe
    • Germany
    • France
    • United Kingdom
    • Italy
    • Spain
    • Russia
    • Others
  • Latin America
    • Brazil
    • Mexico
    • Others
  • Middle East and Africa
     

Competitive Landscape:

The competitive landscape of the industry has also been examined with some of the key players being Beta Bionics Inc., Bigfoot Biomedical Inc., Dexcom Inc., Inreda Diabetic B.V., Insulet Corporation, Johnson & Johnson, Medtronic Inc., Roche Holding AG, Tandem Diabetes Care Inc., etc.

Report Coverage:

Report Features Details
Base Year of the Analysis 2020
Historical Period 2015-2020
Forecast Period 2021-2026
Units US$ Million
Segment Coverage Device Type, Treatment Type, End-User, Region
Region Covered  Asia Pacific, Europe, North America, Latin America, Middle East and Africa
Countries Covered United States, Canada, Germany, France, United Kingdom, Italy, Spain, Russia, China, Japan, India, South Korea, Australia, Indonesia, Brazil, Mexico
Companies Covered Beta Bionics Inc., Bigfoot Biomedical Inc., Dexcom Inc., Inreda Diabetic B.V., Insulet Corporation, Johnson & Johnson, Medtronic Inc., Roche Holding AG and Tandem Diabetes Care Inc.
Customization Scope 10% Free Customization
Report Price and Purchase Option Single User License: US$ 2299
Five User License: US$ 3399
Corporate License: US$ 4499
Post-Sale Analyst Support 10-12 Weeks
Delivery Format PDF and Excel through Email (We can also provide the editable version of the report in PPT/Word format on special request)


Key Questions Answered in This Report:

  • How has the global artificial pancreas device systems market performed so far and how will it perform in the coming years?
  • What are the key regional markets?
  • What has been the impact of COVID-19 on the global artificial pancreas device systems market?
  • What is the breakup of the market based on the device type?
  • What is the breakup of the market based on the treatment type?
  • What is the breakup of the market based on the end-user?
  • What are the various stages in the value chain of the industry?
  • What are the key driving factors and challenges in the industry?
  • What is the structure of the global artificial pancreas device systems market and who are the key players?
  • What is the degree of competition in the industry?

1   Preface
2   Scope and Methodology 

    2.1    Objectives of the Study
    2.2    Stakeholders
    2.3    Data Sources
        2.3.1    Primary Sources
        2.3.2    Secondary Sources
    2.4    Market Estimation
        2.4.1    Bottom-Up Approach
        2.4.2    Top-Down Approach
    2.5    Forecasting Methodology
3   Executive Summary
4   Introduction

    4.1    Overview
    4.2    Key Industry Trends
5   Global Artificial Pancreas Device Systems Market
    5.1    Market Overview
    5.2    Market Performance
    5.3    Impact of COVID-19
    5.4    Market Forecast
6   Market Breakup by Device Type
    6.1    Threshold Suspend Device Systems
        6.1.1 Market Trends
        6.1.2 Market Forecast
    6.2    Control- to-Range Systems
        6.2.1 Market Trends
        6.2.2 Market Forecast
    6.3    Control-to-Target Systems
        6.3.1 Market Trends
        6.3.2 Market Forecast
7   Market Breakup by Treatment Type
    7.1    Bi-hormonal
        7.1.1 Market Trends
        7.1.2 Market Forecast
    7.2    Insulin Only
        7.2.1 Market Trends
        7.2.2 Market Forecast
    7.3    Hybrid
        7.3.1 Market Trends
        7.3.2 Market Forecast
8   Market Breakup by End-User
    8.1    Hospital
        8.1.1 Market Trends
        8.1.2 Market Forecast
    8.2    Medical Centres
        8.2.1 Market Trends
        8.2.2 Market Forecast
    8.3    Others
        8.3.1 Market Trends
        8.3.2 Market Forecast
9   Market Breakup by Region
    9.1    North America
        9.1.1 United States
           9.1.1.1 Market Trends
           9.1.1.2 Market Forecast
        9.1.2 Canada
           9.1.2.1 Market Trends
           9.1.2.2 Market Forecast
    9.2    Asia Pacific
        9.2.1 China
           9.2.1.1 Market Trends
           9.2.1.2 Market Forecast
        9.2.2 Japan
           9.2.2.1 Market Trends
           9.2.2.2 Market Forecast
        9.2.3 India
           9.2.3.1 Market Trends
           9.2.3.2 Market Forecast
        9.2.4 South Korea
           9.2.4.1 Market Trends
           9.2.4.2 Market Forecast
        9.2.5 Australia
           9.2.5.1 Market Trends
           9.2.5.2 Market Forecast
        9.2.6 Indonesia
           9.2.6.1 Market Trends
           9.2.6.2 Market Forecast
        9.2.7 Others
           9.2.7.1 Market Trends
           9.2.7.2 Market Forecast
    9.3    Europe
        9.3.1 Germany
           9.3.1.1 Market Trends
           9.3.1.2 Market Forecast
        9.3.2 France
           9.3.2.1 Market Trends
           9.3.2.2 Market Forecast
        9.3.3 United Kingdom
           9.3.3.1 Market Trends
           9.3.3.2 Market Forecast
        9.3.4 Italy
           9.3.4.1 Market Trends
           9.3.4.2 Market Forecast
        9.3.5 Spain
           9.3.5.1 Market Trends
           9.3.5.2 Market Forecast
        9.3.6 Russia
           9.3.6.1 Market Trends
           9.3.6.2 Market Forecast
        9.3.7 Others
           9.3.7.1 Market Trends
           9.3.7.2 Market Forecast
    9.4    Latin America
        9.4.1 Brazil
           9.4.1.1 Market Trends
           9.4.1.2 Market Forecast
        9.4.2 Mexico
           9.4.2.1 Market Trends
           9.4.2.2 Market Forecast
        9.4.3 Others
           9.4.3.1 Market Trends
           9.4.3.2 Market Forecast
    9.5    Middle East and Africa
        9.5.1 Market Trends
        9.5.2 Market Breakup by Country
        9.5.3 Market Forecast
10  SWOT Analysis
    10.1    Overview
    10.2    Strengths
    10.3    Weaknesses
    10.4    Opportunities
    10.5    Threats
11  Value Chain Analysis
12  Porters Five Forces Analysis

    12.1    Overview
    12.2    Bargaining Power of Buyers
    12.3    Bargaining Power of Suppliers
    12.4    Degree of Competition
    12.5    Threat of New Entrants
    12.6    Threat of Substitutes
13  Price Indicators
14  Competitive Landscape

    14.1    Market Structure
    14.2    Key Players
    14.3    Profiles of Key Players
        14.3.1    Beta Bionics Inc.
           14.3.1.1 Company Overview
           14.3.1.2 Product Portfolio 
        14.3.2    Bigfoot Biomedical Inc.
           14.3.2.1 Company Overview
           14.3.2.2 Product Portfolio 
        14.3.3    Dexcom Inc.
           14.3.3.1 Company Overview
           14.3.3.2 Product Portfolio 
           14.3.3.3 Financials
           14.3.3.4 SWOT Analysis
        14.3.4    Inreda Diabetic B.V.
           14.3.4.1 Company Overview
           14.3.4.2 Product Portfolio 
           14.3.4.3 Financials
        14.3.5    Insulet Corporation
           14.3.5.1 Company Overview
           14.3.5.2 Product Portfolio
           14.3.5.3 Financials
           14.3.5.4 SWOT Analysis
        14.3.6    Johnson & Johnson
           14.3.6.1 Company Overview
           14.3.6.2 Product Portfolio
           14.3.6.3 Financials
           14.3.6.4 SWOT Analysis 
        14.3.7    Medtronic Inc.
           14.3.7.1 Company Overview
           14.3.7.2 Product Portfolio 
        14.3.8    Roche Holding AG
           14.3.8.1 Company Overview
           14.3.8.2 Product Portfolio 
           14.3.8.3 Financials
        14.3.9    Tandem Diabetes Care Inc.
           14.3.9.1 Company Overview
           14.3.9.2 Product Portfolio 
           14.3.9.3 Financials
 

List of Figures


Figure 1: Global: Artificial Pancreas Device Systems Market: Major Drivers and Challenges
Figure 2: Global: Artificial Pancreas Device Systems Market: Sales Value (in Million US$), 2015-2020
Figure 3: Global: Artificial Pancreas Device Systems Market: Breakup by Device Type (in %), 2020
Figure 4: Global: Artificial Pancreas Device Systems Market: Breakup by Treatment Type (in %), 2020
Figure 5: Global: Artificial Pancreas Device Systems Market: Breakup by End-User (in %), 2020
Figure 6: Global: Artificial Pancreas Device Systems Market: Breakup by Region (in %), 2020
Figure 7: Global: Artificial Pancreas Device Systems Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 8: Global: Artificial Pancreas Device Systems (Threshold Suspend Device Systems) Market: Sales Value (in Million US$), 2015 & 2020
Figure 9: Global: Artificial Pancreas Device Systems (Threshold Suspend Device Systems) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 10: Global: Artificial Pancreas Device Systems (Control- to-Range Systems) Market: Sales Value (in Million US$), 2015 & 2020
Figure 11: Global: Artificial Pancreas Device Systems (Control- to-Range Systems) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 12: Global: Artificial Pancreas Device Systems (Control-to-Target Systems) Market: Sales Value (in Million US$), 2015 & 2020
Figure 13: Global: Artificial Pancreas Device Systems (Control-to-Target systems) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 14: Global: Artificial Pancreas Device Systems (Bi-hormonal) Market: Sales Value (in Million US$), 2015 & 2020
Figure 15: Global: Artificial Pancreas Device Systems (Bi-hormonal) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 16: Global: Artificial Pancreas Device Systems (Insulin Only) Market: Sales Value (in Million US$), 2015 & 2020
Figure 17: Global: Artificial Pancreas Device Systems (Insulin Only) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 18: Global: Artificial Pancreas Device Systems (Hybrid) Market: Sales Value (in Million US$), 2015 & 2020
Figure 19: Global: Artificial Pancreas Device Systems (Hybrid) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 20: Global: Artificial Pancreas Device Systems (Hospitals) Market: Sales Value (in Million US$), 2015 & 2020
Figure 21: Global: Artificial Pancreas Device Systems (Hospitals) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 22: Global: Artificial Pancreas Device Systems (Medical Centres) Market: Sales Value (in Million US$), 2015 & 2020
Figure 23: Global: Artificial Pancreas Device Systems (Medical Centres) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 24: Global: Artificial Pancreas Device Systems (Other End-Users) Market: Sales Value (in Million US$), 2015 & 2020
Figure 25: Global: Artificial Pancreas Device Systems (Other End-Users) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 26: North America: Artificial Pancreas Device Systems Market: Sales Value (in Million US$), 2015 & 2020
Figure 27: North America: Artificial Pancreas Device Systems Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 28: United States: Artificial Pancreas Device Systems Market: Sales Value (in Million US$), 2015 & 2020
Figure 29: United States: Artificial Pancreas Device Systems Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 30: Canada: Artificial Pancreas Device Systems Market: Sales Value (in Million US$), 2015 & 2020
Figure 31: Canada: Artificial Pancreas Device Systems Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 32: Asia Pacific: Artificial Pancreas Device Systems Market: Sales Value (in Million US$), 2015 & 2020
Figure 33: Asia Pacific: Artificial Pancreas Device Systems Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 34: China: Artificial Pancreas Device Systems Market: Sales Value (in Million US$), 2015 & 2020
Figure 35: China: Artificial Pancreas Device Systems Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 36: Japan: Artificial Pancreas Device Systems Market: Sales Value (in Million US$), 2015 & 2020
Figure 37: Japan: Artificial Pancreas Device Systems Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 38: India: Artificial Pancreas Device Systems Market: Sales Value (in Million US$), 2015 & 2020
Figure 39: India: Artificial Pancreas Device Systems Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 40: South Korea: Artificial Pancreas Device Systems Market: Sales Value (in Million US$), 2015 & 2020
Figure 41: South Korea: Artificial Pancreas Device Systems Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 42: Australia: Artificial Pancreas Device Systems Market: Sales Value (in Million US$), 2015 & 2020
Figure 43: Australia: Artificial Pancreas Device Systems Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 44: Indonesia: Artificial Pancreas Device Systems Market: Sales Value (in Million US$), 2015 & 2020
Figure 45: Indonesia: Artificial Pancreas Device Systems Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 46: Others: Artificial Pancreas Device Systems Market: Sales Value (in Million US$), 2015 & 2020
Figure 47: Others: Artificial Pancreas Device Systems Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 48: Europe: Artificial Pancreas Device Systems Market: Sales Value (in Million US$), 2015 & 2020
Figure 49: Europe: Artificial Pancreas Device Systems Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 50: Germany: Artificial Pancreas Device Systems Market: Sales Value (in Million US$), 2015 & 2020
Figure 51: Germany: Artificial Pancreas Device Systems Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 52: France: Artificial Pancreas Device Systems Market: Sales Value (in Million US$), 2015 & 2020
Figure 53: France: Artificial Pancreas Device Systems Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 54: United Kingdom: Artificial Pancreas Device Systems Market: Sales Value (in Million US$), 2015 & 2020
Figure 55: United Kingdom: Artificial Pancreas Device Systems Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 56: Italy: Artificial Pancreas Device Systems Market: Sales Value (in Million US$), 2015 & 2020
Figure 57: Italy: Artificial Pancreas Device Systems Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 58: Spain: Artificial Pancreas Device Systems Market: Sales Value (in Million US$), 2015 & 2020
Figure 59: Spain: Artificial Pancreas Device Systems Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 60: Russia: Artificial Pancreas Device Systems Market: Sales Value (in Million US$), 2015 & 2020
Figure 61: Russia: Artificial Pancreas Device Systems Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 62: Others: Artificial Pancreas Device Systems Market: Sales Value (in Million US$), 2015 & 2020
Figure 63: Others: Artificial Pancreas Device Systems Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 64: Latin America: Artificial Pancreas Device Systems Market: Sales Value (in Million US$), 2015 & 2020
Figure 65: Latin America: Artificial Pancreas Device Systems Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 66: Brazil: Artificial Pancreas Device Systems Market: Sales Value (in Million US$), 2015 & 2020
Figure 67: Brazil: Artificial Pancreas Device Systems Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 68: Mexico: Artificial Pancreas Device Systems Market: Sales Value (in Million US$), 2015 & 2020
Figure 69: Mexico: Artificial Pancreas Device Systems Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 70: Others: Artificial Pancreas Device Systems Market: Sales Value (in Million US$), 2015 & 2020
Figure 71: Others: Artificial Pancreas Device Systems Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 72: Middle East and Africa: Artificial Pancreas Device System Market: Sales Value (in Million US$), 2015 & 2020
Figure 73: Middle East and Africa: Artificial Pancreas Device Systems Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 74: Global: Artificial Pancreas Device Systems Industry: SWOT Analysis
Figure 75: Global: Artificial Pancreas Device Systems Industry: Value Chain Analysis
Figure 76: Global: Artificial Pancreas Device Systems Industry: Porter’s Five Forces Analysis

List of Tables

Table 1: Global: Artificial Pancreas Device Systems Market: Key Industry Highlights, 2020 and 2026
Table 2: Global: Artificial Pancreas Device Systems Market Forecast: Breakup by Device Type (in Million US$), 2021-2026
Table 3: Global: Artificial Pancreas Device Systems Market Forecast: Breakup by Treatment Type (in Million US$), 2021-2026
Table 4: Global: Artificial Pancreas Device Systems Market Forecast: Breakup by End-User (in Million US$), 2021-2026
Table 5: Global: Artificial Pancreas Device Systems Market Forecast: Breakup by Region (in Million US$), 2021-2026
Table 6: Global: Artificial Pancreas Device Systems Market: Competitive Structure
Table 7: Global: Artificial Pancreas Device Systems Market: Key Players       

Note: We value your privacy and will never rent or sell your email address. Privacy policy

Need more help?

  •   Speak to our experienced analysts for insights on the current market scenarios.
  •   Include additional segments and countries to customize the report as per your requirement.
  •   Gain an unparalleled competitive advantage in your domain by understanding how to utilize the report and positively impacting your operations and revenue.
  •   For further assistance, please connect with our analysts.

Purchase Options




$ 2299

REACH OUT TO US

Call us on

( US: +1-631-791-1145 )
( UK: +44-753-713-2163 )
( India: +91 120 433 0800 )


Drop us an email at

sales@imarcgroup.com

Social Links